Table 1.

Patient Demographics

Characteristic	n
Total	29
Age group (yrs)
20–39	4 (13.8%)
40–49	5 (17.2%)
50–59	4 (13.8%)
60–69	15 (51.7%)
70 +	1 (3.4%)
Gender
Male	22 (75.9%)
Female	7 (24.1%)
Medical comorbidity
Present	5 (17.2%)
Absent	24 (82.8%)
Pathology
Adenoid cystic carcinoma	3 (10.3%)
Olfactory neuroblastoma	5 (17.2%)
Squamous cell carcinoma	11 (37.9%)
Adenosquamous cell carcinoma	2 (6.9%)
Rhabdomyosarcoma	1 (3.4%)
Benign	7 (24.1%)
Prior therapy*
Present	21 (70%)
Surgery alone	4 (13.3%)
Radiation alone	13 (43.3%)
Surgery + radiation	3 (10%)
Chemotherapy alone	1 (3.3%)
Absent	9 (30%)

^*Based on 30 cases of skull base surgery.